Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: Pathogenesis, epidemiology, and management. J Sex Med. 2010;7:476–500. https://doi.org/10.1111/j.1743-6109.2009.01625.x.
Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, et al. EAU Working Group on Male Sexual and Reproductive Health. European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual Dysfunction. Eur Urol. 2021;80:333–57. https://doi.org/10.1016/j.eururo.2021.06.007.
Muneer A, Cellek S, Ralph DJ, Minhas S. The investigation of putative agents, using an in vitro model, to prevent cavernosal smooth muscle dysfunction during low-flow priapism. BJU Int. 2008;102:988–92. https://doi.org/10.1111/j.1464-410X.2008.07778.x.
Burnett AL, Sharlip ID. Standard operating procedures for priapism. J Sex Med. 2013;10:180–94. https://doi.org/10.1111/j.1743-6109.2012.02707.x.
Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, Song F, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7:1–173. https://doi.org/10.3310/hta7270.
13 Including non-randomized studies n.d. https://handbook-5-1.cochrane.org/chapter_13/13_including_non_randomized_studies.htm (accessed June 5, 2021).
Bansal AR, Godara R, Garg P. Cold saline enema in priapism—a useful tool for underprivileged. Trop Doct. 2004;34:227–8. https://doi.org/10.1177/004947550403400414.
Bardin ED, Krieger JN. Pharmacological priapism: comparison of trazodone- and papaverine-associated cases. Int Urol Nephrol. 1990;22:147–52. https://doi.org/10.1007/BF02549833.
CAS Article PubMed Google Scholar
Jiang P, Christakos A, Fam M, Sadeghi-Nejad H. Prophylactic phenylephrine for iatrogenic priapism: a pilot study with Peyronie’s patients. Korean J Urol. 2014;55:665–9. https://doi.org/10.4111/kju.2014.55.10.665.
Article PubMed PubMed Central Google Scholar
Kadioglu A, Cayan S, Tunc M, Tellaloglu S. The use of methylene blue in the treatment of paraverine induced prolonged erection. Med Bull Instanbul. 1995;28–30.
Keskin D, Cal C, Delibas M, özyurt C, Günaydin G, Nazli O, et al. Intracavernosal adrenalin injection in priapism. Int J Impot Res. 2000;12:312–4. https://doi.org/10.1038/sj.ijir.3900539.
CAS Article PubMed Google Scholar
Khurana P, Bansal AR, Kamal H, Malik V. Role of cold saline enema in management of priapism. Indian J Urol. 2002;18:146–7.
Kulmala R. Treatment of priapism: primary results and complications in 207 patients. Ann Chir Gynaecol. 1994;83:309–14.
Kumar M, Garg G, Sharma A, Pandey S, Singh M, Sankhwar SN. Comparison of outcomes in malignant vs. non-malignant ischemic priapism: 12-year experience from a tertiary center. Turkish J Urol. 2019;45:340–4. https://doi.org/10.5152/tud.2019.75044.
Larocque MA, Cosgrove MD. Priapism: a review of 46 cases. J Urol. 1974;112:770–3. https://doi.org/10.1016/s0022-5347(17)59848-1.
CAS Article PubMed Google Scholar
Martínez Portillo F, Hoang-Boehm J, Weiss J, Alken P, Jünemann K. Methylene blue as a successful treatment alternative for pharmacologically induced priapism. Eur Urol. 2001;39:20–3. https://doi.org/10.1159/000052407.
Molina L, Bejany D, Lynne CM, Politano VA. Diluted epinephrine solution for the treatment of priapism. J Urol. 1989;141:1127–8. https://doi.org/10.1016/s0022-5347(17)41189-x.
CAS Article PubMed Google Scholar
Moloney PJ, Elliott GB, Johnson HW. Experiences with priapism. J Urol. 1975;114:72–6. https://doi.org/10.1016/s0022-5347(17)66946-5.
CAS Article PubMed Google Scholar
deHoll JD, Shin PA, Angle JF, Steers WD. Alternative approaches to the management of priapism. Int J Impot Res. 1998;10:11–4. https://doi.org/10.1038/sj.ijir.3900308.
CAS Article PubMed Google Scholar
Muruve N, Hosking DH. Intracorporeal phenylephrine in the treatment of priapism. J Urol. 1996;155:141–3.
Pantaleo-Gandais M, Chalbaud R, Chacon O, Plaza N. Priapism: evaluation and treatment. Urology. 1984;24:345–6. https://doi.org/10.1016/0090-4295(84)90207-3.
CAS Article PubMed Google Scholar
Passavanti G, Bragaglia A, Paolini R. From methylene blue (methylthionine chloride) to Al-Ghorab procedure: the therapy of priapism (our experience). Arch Ital Di Urol Androl Organo Uff [Di] Soc Ital Di Ecogr Urol e Nefrol. 2009;81:242–4.
Ridyard DG, Phillips EA, Vincent W, Munarriz R. Use of high-dose phenylephrine in the treatment of ischemic priapism: five-year experience at a single institution. J Sex Med. 2016;13:1704–7. https://doi.org/10.1016/j.jsxm.2016.09.010.
Saffon Cuartas JP, Sandoval-Salinas C, Martínez JM, Corredor HA. Treatment of priapism secondary to drugs for erectile dysfunction. Adv Urol. 2019;2019:6214921 https://doi.org/10.1155/2019/6214921.
Article PubMed PubMed Central Google Scholar
Serrate RG, Prats J, Regué R, Rius G. The usefulness of ethylephrine (Efortil-R) in the treatment of priapism and intraoperative penile erections. Int Urol Nephrol. 1992;24:389–92. https://doi.org/10.1007/BF02550631.
CAS Article PubMed Google Scholar
Soler J-M, Previnaire J-G, Mieusset R, Plante P. Oral midodrine for prostaglandin e1 induced priapism in spinal cord injured patients. J Urol. 2009;182:1096–100. https://doi.org/10.1016/j.juro.2009.05.009.
Sönmez MG, Kara C, Karaibrahimoğlu A, Sönmez LÖ, Göğer YE, Balasar M, et al. Ischemic priapism: can eosinophil count and platelet functions be positive predictive factors in etiopathogenesis. Can Urol Assoc J = J l’Association Des Urol Du Can. 2017;11:E297–301. https://doi.org/10.5489/cuaj.4263.
Stief CG, Gall H, Scherb W, Bähren W. Mid-term results of autoinjection therapy for erectile dysfunction. Urology. 1988;31:483–5. https://doi.org/10.1016/0090-4295(88)90212-9.
CAS Article PubMed Google Scholar
Török A, Jilling A, Götz F. Induced priapism and its management. Int Urol Nephrol. 1991;23:191–4. https://doi.org/10.1007/BF02549718.
Dittrich A, Albrecht K, Bar-Moshe O, Vandendris M. Treatment of pharmacological priapism with phenylephrine. J Urol. 1991;146:323–4. https://doi.org/10.1016/s0022-5347(17)37781-9.
CAS Article PubMed Google Scholar
van Driel MF, Mooibroek JJ, Mensink HJ. Treatment of priapism by injection of adrenaline into the corpora cavernosa penis. Scand J Urol Nephrol. 1991;25:251–4. https://doi.org/10.3109/00365599109024554.
Vorobets D, Banyra O, Stroy A, Shulyak A. Our experience in the treatment of priapism. Cent Eur. J Urol. 2011;64:80–3. https://doi.org/10.5173/ceju.2011.02.art6.
Watters GR, Keogh EJ, Carati CJ, Earle CM, Wisniewski ZS, Tulloch AG, et al. Prolonged erections following intracorporeal injection of medications to overcome impotence. Br J Urol. 1988;62:173–5. https://doi.org/10.1111/j.1464-410x.1988.tb04301.x.
CAS Article PubMed Google Scholar
Ugwumba FO, Ekwedigwe HC, Echetabu KN, Okoh AD, Nnabugwu I, Ugwuidu ES. Ischemic priapism in South-East Nigeria: Presentation, management challenges, and aftermath issues. Niger J Clin Pr. 2016;19:207–11. https://doi.org/10.4103/1119-3077.175968.
Zhao H, Berdahl C, Bresee C, Moradzadeh A, Houman J, Kim H, et al. Priapism from Recreational Intracavernosal Injections in a High-Risk Metropolitan Community. J Sex Med. 2019;16:1650–4. https://doi.org/10.1016/j.jsxm.2019.07.024.
Article PubMed PubMed Central Google Scholar
Zhao H, Dallas K, Masterson J, Lo E, Houman J, Berdahl C, et al. Risk factors for surgical shunting in a large cohort with ischemic priapism. J Sex Med. 2020;17:2472–7. https://doi.org/10.1016/j.jsxm.2020.09.007.
Article PubMed PubMed Central Google Scholar
Masterson JM, Zhao H, Choi E, Kim HH, Anger JT. Characteristics and long term follow up of men who suffer ischemic priapism secondary to recreational use of intracavernosal injectable medications. Urology. 2021:1–6. https://doi.org/10.1016/j.urology.2021.06.036.
Dutta R, Matz EL, Overholt TL, Anderson WB, Deebel NA, Cowper M, et al. Patient education is associated with reduced delay to presentation for management of ischemic priapism: a retrospective review of 123 men. J Sex Med. 2021;18:385–90. https://doi.org/10.1016/j.jsxm.2020.11.017.
CAS Article PubMed Google Scholar
Palka J, DuComb W, Begun E, Soto-Aviles O. Factors associated with corporoglandular shunting for patients with first-time ischemic priapism. Urology. 2021;154:191–5. https://doi.org/10.1016/j.urology.2021.03.030.
Patel PM, Slovacek H, Pahouja G, Patel HD, Cao D, Emerson J, et al. Socioeconomic disparities and risk factors in patients presenting with ischemic priapism: a multi-institutional study. Urology 2021:1–6. https://doi.org/10.1016/j.urology.2021.03.063.
El-Bahnasawy MS, Dawood A, Farouk A. Low-flow priapism: risk factors for erectile dysfunction. BJU Int. 2002;89:285–90. https://doi.org/10.1046/j.1464-4096.2001.01510.x.
CAS Article PubMed Google Scholar
FARRER JF, GOODWIN WE. Treatment of priapism: comparison of methods in fifteen cases. J Urol. 1961;86:768–75. https://doi.org/10.1016/s0022-5347(17)65259-5.
CAS Article PubMed Google Scholar
Forsberg L, Hederström E, Olsson AM. Severe arterial insufficiency in impotence confirmed with an improved angiographic technique: the impact of smoking and some other etiologic factors. Eur Urol. 1989;16:357–60. https://doi.org/10.1159/000471616.
CAS Article PubMed Google Scholar
Gordon SA, Stage KH, Tansey KE, Lotan Y. Conservative management of priapism in acute spinal cord injury. Urology. 2005;65:1195–7. https://doi.org/10.1016/j.urology.2004.12.036.
留言 (0)